Status:

COMPLETED

Individualized Antiretroviral Therapy

Lead Sponsor:

Hospital Italiano de Buenos Aires

Conditions:

Pharmacogenetics

HIV

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The efficacy and safety of antiretroviral therapy and the damage caused by chronic inflammation in the presence of the virus has recently lead to the consideration of initiating antiretroviral therapy...

Detailed Description

I) General Objectives To establish the overall impact of pharmacogenomic (PG) analysis and therapeutic drug monitoring (TDM) for the selection of the proper dose of efavirenz or atazanavir in patients...

Eligibility Criteria

Inclusion

  • Adult patients with diagnosis of chronic HIV infection confirmed by Western blot and / or HIV viral load
  • Patients in whom (according to the judgment of the treating physician) antiretroviral therapy should be initiated and this treatment will be a regimen based on Efavirenz or Atazanavir.
  • Availability of a baseline genotyping test confirming the absence of primary resistance for the selected drugs.
  • Signature of the informed Consent Form

Exclusion

  • Patients who remain untreated or those treated with a regimen that does not include efavirenz or atazanavir
  • Lack of understanding of the study characteristics or rejection to have samples taken for the pharmacological studies.
  • Patients who are not expected to continue their follow-up at the research center for at least one year
  • Patients with coinfections or comorbidities that prevent a dose adjustment of efavirenz or atazanavir based on pharmacological parameters.

Key Trial Info

Start Date :

October 5 2017

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2019

Estimated Enrollment :

190 Patients enrolled

Trial Details

Trial ID

NCT03385473

Start Date

October 5 2017

End Date

December 31 2019

Last Update

September 9 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Italiano de Buenos Aires - Infectious Diseases Section

Buenos Aires, Buenos Aires F.D., Argentina, 1181